2025 TLCS 肺癌衛教工作坊

l   Optimal treatment strategy for late-stage NSCLC patient: Recent advance in NSCLC treatment

Recent advances in NSCLC treatment have significantly improved outcomes for late-stage patients. Optimal strategies now include targeted therapies, immunotherapy, and personalized medicine, offering new hope and extending survival rates. This review explores the latest breakthroughs and their impact on treatment protocols for non-small cell lung cancer (NSCLC) patients.

l   Prevention and Management of Tyrosine Kinase Inhibitor-Related Skin Toxicities in NSCLC

Effective prevention and management of tyrosine kinase inhibitor-related skin toxicities in NSCLC are crucial for patient quality of life. Recent strategies include proactive skincare, dose adjustments, and multidisciplinary approaches. This review highlights the latest advancements and practical guidelines to mitigate these common adverse effects in non-small cell lung cancer treatment.

l   Cardio-oncology The Art of Management in Cardiovascular Dysfunction

Cardio-oncology focuses on managing cardiovascular dysfunction in cancer patients. This field combines cardiology and oncology expertise to address heart-related side effects of cancer treatments. Recent advancements emphasize early detection, personalized care, and multidisciplinary approaches to improve patient outcomes and quality of life.

l   Optimize treatment outcome for EGFRm+ NSCLC patient- Clinical practice sharing

Optimizing treatment outcomes for EGFRm+ NSCLC patients involves sharing clinical practices and experiences. This review highlights personalized treatment plans, targeted therapies, and multidisciplinary approaches that enhance patient care. Recent advancements and practical insights aim to improve survival rates and quality of life for these patients.